[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Pages 46533-46534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-0852]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Prevalence Survey of Healthcare-Associated
Infections and Antimicrobial Use in U.S. Acute Care Hospitals to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on June 10, 2019 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
[[Page 46534]]
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 12/31/2019)--Extension--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and improving
antimicrobial use (AU) are CDC and national priorities. An essential
step in reducing the occurrence of HAIs is to estimate accurately the
burden of these infections in U.S. acute care hospitals and to describe
the types of HAIs and causative pathogens. Periodic assessments of the
magnitude and types of HAIs and AU occurring in all patient populations
within acute care hospitals are needed to inform decisions by policy
makers and hospital infection control personnel (ICP) regarding
appropriate targets and strategies for HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four prevalence surveys (i.e., pilot
survey in 2009, limited-scale survey in 2010, and two full-scale
surveys in 2011 and 2015) in partnership with the CDC's Emerging
Infections Program (EIP) sites. Findings from the most recent survey
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011.
Minor adjustments to data collection instruments since the previous
2016 OMB approval have been made. These adjustments were made to
enhance future analyses and utility of the survey data. These changes
are non-substantive and are not expected to increase the public
reporting burden. An Extension of the prevalence survey's existing OMB
approval is sought to allow a repeat HAI and AU Prevalence Survey to be
performed in 2020. A repeat survey will allow assessment of changes in
HAI and AU prevalence, pathogen distribution, and quality of
antimicrobial prescribing. These data will also allow CDC and its
partners to continue to monitor HAI and AU trends, to measure progress
in meeting national targets, and to further refine prevention
strategies.
In the 2020 survey, data collection will occur within acute care
general hospitals of varying size in each of the 10 EIP sites (i.e.,
CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN). ICP in participating
hospitals may assist EIP site personnel in collecting demographic and
limited clinical data from the electronic or paper-based medical
records of a sample of randomly selected patients on a single day in
2020. Patients will not be interviewed, and no direct interaction with
patients will occur. Hospital and patient-level data will be collected
using unique identification codes. EIP site personnel will submit
hospital and patient-level data to CDC using a secure data management
system. Based on experiences from previous surveys, the time required
to complete the Healthcare Facility Assessment Form (HFA) and Patient
Information Form (PIF) is estimated to be 45 and 17 minutes,
respectively. To conduct the full-scale survey in a three-year approval
period, 100 hospital respondents will complete the HFA 1x and the PIF
on average 63 x per year. The total estimated annualized public burden
is 1,860 hours, which represents no change from the 2016 OMB approval.
To assess changes in HAIs and AU over time, EIP sites will seek
participation from the same hospitals that participated in prior
surveys. These hospitals were originally selected for participation
using a stratified random sampling scheme based on the number of
staffed acute care beds (i.e., small: <150 staffed beds; medium: 151-
399 staffed beds; large: >400 staffed beds). Each site will also have
the option to recruit additional hospitals for a total of up to 30 in
each site. As in previous surveys, hospital participation will remain
voluntary. Within each participating hospital, EIP site personnel will
establish patient sample size targets based on the number of staffed
acute care beds (e.g., up to 75 patients in small hospitals, 75
patients in medium hospitals, and 100 patients in large hospitals). The
estimated annual burden hours are 1860. There are no costs to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (i.e., HFA *............. 100 1 45/60 75
Infection Preventionist).
PIF **............ 100 63 17/60 1785
----------------------------------------------------------------------------------------------------------------
* HFA: Healthcare Facility Assessment.
** PIF: Patient Information Form.
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-19018 Filed 9-3-19; 8:45 am]
BILLING CODE 4163-18-P